Recent Headlines
Within Biotechnology
Your Stem Cell Success Stories Can Help Bring Hope to Others
HopeCell.org Founders Invite Stem Cell Patients to Share Their Experiences and Successes - September 29, 2013 - HopeCell
Pipette.com Announces Promotional T-Shirt and Other Specials for Neuroscience 2013
Pipette.com, distributor of liquid handling products, is attending Neuroscience 2013. They will be answering questions, demoing products, and raffling promotional t-shirts in Booth #3331. - September 28, 2013 - Pipette.com
Phase Focus Announces the Delivery and Installation of a Lens Profiler Instrument to the Brien Holden Vision Institute in Sydney, Australia
Phase Focus Limited is pleased to announce the successful delivery and installation of a Lens Profiler Instrument to the Brien Holden Vision Institute in Sydney, Australia; one of the world’s leading applied vision correction research institutes. This innovative instrument uses the Phase... - September 28, 2013 - Phase Focus
Multichannel Pipettes Promotion Now Available at Pipette.com
Pipette.com, major distributor of liquid handling products, has announced their extension of promotions on multichannel pipettes. The promotions will help labs increase productivity. - September 26, 2013 - Pipette.com
Dr. Len Imas Awarded ONR Grant to Investigate Applicability of Probabalistic Computational Fluid Dynamic Methods to Problems Involving Cavitation
Researcher develops more realistic simulation of flows around partially-cavitating hydrofoils - September 25, 2013 - Stevens Institute of Technology
Stevens Researcher Awarded ONR Grant to Advance Understanding of Planing Hull Hydrodynamics and Design
Dr. Len Imas applies computational modeling to investigate hydrodynamics of “ultra-deep vee” hulls. - September 25, 2013 - Stevens Institute of Technology
Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory
After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (http://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official... - September 22, 2013 - Creative Biomart
Colorado BioScience Association Partners with Two of the State’s Economic Development Entities to Promote Colorado’s Strengths at AdvaMed 2013
Representatives from the Colorado BioScience Association, the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will showcase Colorado’s medical device and diagnostic sectors during the 2013 AdvaMed: The MedTech Conference in Washington D.C., September 23-25. - September 20, 2013 - Colorado BioScience Association
SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis
Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.
Dr. Eui-Hyeok Yang Commences Term as ASME MEMS Division Chair
MEMS expert recognized for commitment to innovation through collaboration and education. - September 18, 2013 - Stevens Institute of Technology
30+ Life Science Investors & Strategic Partners Convene in Denver This Week for 2013 Rocky Mountain Life Science Investor & Partnering Conference
More than 30 leading investors and strategic partners from across the country will come to Denver to connect and invest in the region's emerging life science companies at the 2013 Rocky Mountain Life Science Investor & Partnering Conference. Spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — the conference opens with a reception at the Colorado Governor’s Mansion September 18th. - September 16, 2013 - Colorado BioScience Association
NIH Awards Advaita $2.0M for Disease Subtyping and Drug Repurposing Technology Development
The National Institute of General Medical Sciences of the National Institutes of Health issued a Notice of Award granting a Fast-Track Small Business Investigational Research (SBIR) Phase I and Phase II grant of $2.0 million for Advaita Bioinformatics, of Plymouth, Michigan to develop biological... - September 13, 2013 - Advaita
AveXis Inc. Names Director, Scientific and Corporate Affairs
AveXis Inc. (avexisinc.com), a synthetic biology platform company, today announced Mindy Du as the company’s new Director of Scientific and Corporate Affairs. This is an essential position within the company, as AveXis is focused on research/development of leading-edge technology for disease... - September 13, 2013 - AveXis Inc.
Silicon Kinetics® Ramps Commercial Efforts for Affinity Capture-Mass-Spectrometry (AC-MS)
Appoints Jay Smith as CEO and Keith Waddell as VP Business Development - September 12, 2013 - Silicon Kinetics
Collaborators Awarded NSF Grant for More Efficient Wireless Networks
Researchers aim to end the scarcity of wireless spectrum with dynamic and efficient access. - September 11, 2013 - Stevens Institute of Technology
Meditech Global, Inc. to Attend the 9th World Meeting on Pharmaceutics, Bio-Pharmaceutics and Pharmaceutical Technology
Meditech Global, Inc., a healthcare and Life Science venture capital company, is pleased to announce they will be attending the 9th World Meeting on Pharmaceutics, Bio-pharmaceutics and Pharmaceutical Technology. - September 10, 2013 - Meditech Global Inc
Bioo Scientific Honored with Technology Award
Bioo Scientific, an Austin, Texas-based biotechnology company founded in 2003, that is focused on developing and marketing life science research products, was honored yesterday with the 2013 General Motors Technology Award for Small Businesses at the 13th Annual Greater Austin Business Awards, held... - September 08, 2013 - Bioo Scientific
Stevens Researcher Awarded Collaborative NSF Grant to Understand Bimetallic Nanoparticles for Renewable Energy
Innovative research targets fundamentals of biomass conversion into fuels and chemicals over catalytic bimetallic nanoparticles. - September 06, 2013 - Stevens Institute of Technology
SafeStitch Medical Completes Merger with TransEnterix
$30 Million Financing Raised from Existing TransEnterix and SafeStitch Medical Stockholders, Combined Company to be Renamed TransEnterix. - September 06, 2013 - TransEnterix
Leading CEOs Keynote 2013 Rocky Mountain Life Science Investor & Partnering Conference in Denver
CEOs from Clovis Oncology and Array BioPharma will keynote the opening breakfast at the 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) September 19 at The Ritz-Carlton, Denver. In addition, the conference luncheon will feature Jeff Calcagno, M.D., Principal, Venture Investments, Johnson & Johnson Development Corporation. - September 03, 2013 - Colorado BioScience Association
SFL’s Managing Director Invited to Share Expertise at “Pharma Meets Medtech” Event
SFL's Managing Director offers insights for better pharm and medtech collaboration - September 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Pipette.com Has Extended Their Summer Promotions on Pipettes to Help Alleviate Sequestration Challenges
Pipette.com, major liquid handling products distributor, is extending their summer promotions on pipettes. The extension of these promotions will benefit labs dealing with budget cuts and looking to save money. - August 29, 2013 - Pipette.com
Stevens Researcher Awarded NIST Grant to Standardize Depth-Resolving Optical Imaging
Emerging technologies could help detect numerous diseases at earlier stages of development - August 28, 2013 - Stevens Institute of Technology
CHI Interviews Janet L. Lathey, Ph.D of Emergent BioSolutions on Optimizing Bioassays for Biologics
Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefense Division, Emergent BioSolutions sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, new tools and strategies that researchers are using to combat it, and... - August 26, 2013 - Cambridge Healthtech Institute
Bioo Scientific Launches Test Strips for Ractopamine and Clenbuterol Screening at AOAC 2013
Bioo Scientific will showcase new AuroFlow™ Ractopamine Strip Test Kits and AuroFlow™ RC Combo Strip Test Kits for the detection of ractopamine and clenbuterol in swine urine, at booth #118 of the 127th AOAC Annual Meeting, August 25-28 in Chicago, IL. The AuroFlow™ Ractopamine... - August 25, 2013 - Bioo Scientific
Stem Cell Research and Therapy Website Provides Hope for Future Treatment
New Website Launched to Connect Patients and Inspire Hope of a Healthy Future Through Stem Cells - August 25, 2013 - HopeCell
Creative Biomart Launches Controlled Randomization Service for Random Nucleotide Substitutions
The GenePowerTM Controlled Randomization technology allows you to accurately direct the effective frequency of random nucleotide substitutions. And unlike error-prone PCR, you decide exactly which part(s) of the gene are affected—randomize the entire open reading frame or confine the mutagenesis to specific regions. - August 24, 2013 - Creative Biomart
Pipette.com Has Announced Their Universal Pipette Filter Tip Promotion to Benefit Labs Dealing with Budget Cuts
Pipette.com, leading liquid handling product distributor, announces their universal pipette filter tip promotion. This promotion allows labs impacted by sequestration to extend their plastic consumable budget. - August 23, 2013 - Pipette.com
Zenalux Research Partnership with Roswell Park Cancer Institute Deploys Zenascope™ PC1 in Interstitial Photodynamic Therapy
Zenalux Biomedical, Inc., a biomedical diagnostics company, is now collaborating with Roswell Park Cancer Institute through the Zenalux Research Partnership program. The partnership has been formed to enable Roswell to use the Zenascope™ PC1 for interstitial photodynamic therapy. The PC1 will... - August 22, 2013 - Zenalux Biomedical, Inc.
AveXis Inc. Names Director of Clinical Operations and Research
AveXis Inc. (avexisinc.com), a synthetic biology platform company, today announced Minna Du as the company’s Director of Clinical Operations and Research. This is a critical position within the company, as AveXis is focused on research/development of technology for disease treatment. - August 21, 2013 - AveXis Inc.
Stevens Research Honored in Highlights 2012 Issue of Nanotechnology Journal
Innovation in battery technology could drastically cut charge-time for mobile devices - August 21, 2013 - Stevens Institute of Technology
AbboMax, Inc. Announces the Availability of a Portfolio of 23 Stem Cell Research Antibodies
Stem cell research is one of the most fascinating areas of modern biology. AbboMax offers 23 antibodies for stem cell research. Among them antibodies for FOX (Forkhead box) proteins, a family of transcription factors that play important roles in regulating the expression of genes involved in cell growth, proliferation, differentiation, and metabolism. Selected anti- FOXA-1,2,3 and Anti- FOXP-1,2,3 antibodies are validated for use in Western blot. - August 20, 2013 - AbboMax, Inc.
Creative Biomart Releases New Antibody Products—Nanobodies
Creative Biomart releases new antibody products, nanobodies, recently. Compared to conventional antibodies, nanobodies also integrate the features of small molecules. - August 18, 2013 - Creative Biomart
Genohub Launches Next Generation Sequencing Marketplace
Genohub announced the launch of their online market for next generation sequencing services today. - August 17, 2013 - Genohub
MoBiTec GmbH, Germany, is Offering SURE Gene Expression System for Bacillus Subtilis, Regulated by Subtilin
A system for SUbtilin-Regulated gene Expression (SURE) in Bacillus subtilis is offered. Subtilin is a small peptide antibiotic produced by Bacillus subtilis. The SURE system provides an alternative to, e.g., IPTG or xylose inducible systems. - August 17, 2013 - MoBiTec GmbH
Cheers: Researchers Identified New Brain Markers with Creative Biomart’s S100B Antibody
In the study, researchers used the critical products purchased from Creative Biomart. During the process, the serum levels of molecular markers were determined by ELISA using antibodies and antigens from Creative Biomart (New York, NY) (S100B) which you can see in the article. - August 16, 2013 - Creative Biomart
Experts from Creative Biomart Share the Experience on Using Elisa Kits to Improve the Precision of an Assay
There are some issues that researchers might meet in the process of using ELISA Kits. In order to help improve the precision of an assay, Creative Biomart (http://www.creativebiomart.net/) experts concluded the following tips for reference. - August 14, 2013 - Creative Biomart
Heart Stem Cell Therapy Offers a New Chance for Heart Disease Patients
New Website Launched to Enlighten Patients and Guide them to Health. - August 13, 2013 - HopeCell
Rocky Mountain Life Science Investor & Partnering Conference Announces Thirty Regional Companies for 2013 Presentation Lineup
The 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 18-19 at The Ritz-Carlton, Denver. - August 12, 2013 - Colorado BioScience Association
Scientific Breakthrough in Carbon Nanotube Photonics
Ultraclean carbon nanotubes hold promise for advances in optical fiber communications, solar cells and LEDs - August 09, 2013 - Stevens Institute of Technology
Stevens Researcher Wins Army Research Office Grant to Ensure Secure Wireless Communication
Research provides resilient encryption in the absence of supporting infrastructure - August 08, 2013 - Stevens Institute of Technology
Research Antibody Survey: Creative Biomart Conducted a Survey Among Antibodies Users
In order to direct market and perfect products, Creative Biomart conducted the survey. And the survey results are listed as follows. - August 03, 2013 - Creative Biomart
AveXis Inc. Names Chief Scientific Officer
AveXis Inc. (avexisinc.com), a synthetic biology platform company focused on research and development of technology for disease treatment, today announced Dr. Allan A. Kaspar will serve as the company’s first Chief Scientific Officer (CSO). Dr. Kaspar has held research positions at multiple... - August 01, 2013 - AveXis Inc.
HEEDS Portal to MSC Adams Product Line Released
Red Cedar Technology announced today that it has released a new full-featured portal linking HEEDS to the MSC Adams product line, including Adams/View, Adams/Car, and Adams/Chassis. - July 31, 2013 - Red Cedar Technology
Pipette.com, Major Liquid Handling Distributor, Has Increased Their Bottletop Dispenser Stock
Pipette.com has increased their stock of bottletop dispensers, boosting their already extensive assortment of high quality liquid handling products. - July 31, 2013 - Pipette.com
Wescadia Group’s White Paper - Pursuing Growth: Optimizing Business Development Opportunities
Wescadia Group, a healthcare consultancy firm, announces the release of its white paper entitled “Pursuing Growth: Optimizing Business Development Opportunities.” - July 31, 2013 - Wescadia Group Pty Ltd
Biotech Company and Craft Beer Association Partner to Advance Craft Beer Education
San Antonio’s newest biotech company, Alamo Yeast Labs, and local craft beer association, the San Antonio Cerveceros, have partnered to create a unique craft beer experience called: Brewatory. Brewatory is a taproom, laboratory and educational center dedicated to educating craft beer enthusiasts about the science behind brewing. - July 30, 2013 - Brewatory
Final Agenda Announced for CHI’s FAST: Functional Analysis & Screening Technologies Congress
Headlined by Karen Burg, DL Taylor, Steve Ludbrook and Aaron Morris, CHI's FAST Congress features three days of innovative presentations for more accurate biological response in drug discovery through novel screening technologies and strategies. - July 27, 2013 - Cambridge Healthtech Institute
New Company Formed to Focus on New Technology for Disease Treatment
AveXis Inc. (avexisinc.com) announced its formation as a company focused on research and development of technology specifically for disease treatment. A synthetic biology platform company, AveXis has, at its core, a desire to establish unique industry alliances which will bring innovative... - July 27, 2013 - AveXis Inc.
New Research Validates Importance of Central Lab to Overall Investigator Satisfaction
More than 250 Clinical Investigators Indicate Central Lab Preference - July 26, 2013 - Life Science Strategy Group, LLC